Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of ...

HousingWire's Tech Pulse roundup reveals key PropTech developments, including slow AI adoption among agents, successful title fraud prevention, and new compliance tools. Partnerships and AI assistants ...

OpenAI products and ideas are spooking investors and redefining industries like SaaS, e-commerce, and digital advertising.

This summary is reviewed by TRD Staff. Docusign is looking to expand its San Francisco headquarters by leasing an additional two floors at 221 Main Street, adding approximately 50,000 square feet to ...

Fintel reports that on October 3, 2025, JMP Securities reiterated coverage of DocuSign (NasdaqGS:DOCU) with a Market Outperform recommendation. Analyst Price Forecast Suggests 38.54% Upside As of ...

DocuSign, Inc. (NASDAQ:DOCU) is one of the best most oversold large cap stocks so far in 2025. On September 8, Morgan Stanley raised the firm’s price target on DocuSign, Inc. (NASDAQ:DOCU) to $90 from ...

Shares of electronic signature company DocuSign (NASDAQ:DOCU) fell 4.2% in the afternoon session after the stock continued to decline as ChatGPT developer OpenAI unveiled a new competing product, ...

Lenders seized 1019 Market St., once Zendesk's Mid-Market headquarters, at a public auction in September.

Digital payments are common, but they aren’t without their risks. Here are six rules to help you enjoy the speed and security of sending money online.

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks.com, Bazinet is a ...

As real estate technology advances, customer expectations evolve. Accustomed to the ease and speed of e-commerce, many buyers and sellers expect the same from their real estate platforms. They want ...

The pharmaceutical industry is thriving, fueled by steady demand for drugs, cost-efficient alternative discoveries, and rapid technological innovations. Hence, fundamentally strong pharma stocks Novo ...